Table: Ono Pharm -2017/18 group results (IFRS)

ONO PHARMACEUTICAL

10/05/2018 04:00

May 10 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Mar 31, 2018    Mar 31, 2017   Mar 31, 2019      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            261.84          244.80         277.00        134.50   
                 (+7.0 pct)      (+52.7 pct)    (+5.8 pct)   (+10.7 pct) 
  Operating         60.68           72.28          61.50         28.50   
                 (-16.0 pct)    (+136.9 pct)    (+1.3 pct)    (+6.4 pct) 
  Pretax            63.92           74.54          65.00         30.00   
                 (-14.2 pct)    (+124.0 pct)    (+1.7 pct)    (+5.7 pct) 
  Net               50.28           55.79          50.50         23.00   
                 (-9.9 pct)     (+123.4 pct)    (+0.4 pct)    (+8.4 pct) 
  EPS Basic       97.00 yen      105.27 yen      98.23 yen    44.74 yen  
  EPS Diluted     96.99 yen      105.26 yen                              
  Ann Div         45.00 yen       40.00 yen      45.00 yen               
  -Q2 Div         25.00 yen       20.00 yen      22.50 yen               
  -Q4 Div         20.00 yen       20.00 yen      22.50 yen               
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T